Revance Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 6.96, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Revance Therapeutics Inc 's Accounts Receivable average collection period in the Sep 30 2024 quarter, has increased to 52 days, from 45 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 215 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1901, from overall ranking in the second quarter 2024 at 1991.

What is Receivable Turnover Ratio?
What is Revance Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RVNC Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Receivable Change	89.91 %	111.75 %	94.41 %	144.08 %	116.62 %
Y / Y Revenue Change	5.47 %	12.48 %	5.28 %	39.82 %	95.68 %
Receivable Turnover Ratio (TTM)	6.96	8.19	9.46	10.95	12.38
RVNC's Total Ranking	# 1901	# 1991	# 1993	# 729	# 515
Accounts Receivable average collection period days	52	45	39	33	29
Seq. Receivable Change	33.74 %	20.75 %	7.99 %	8.9 %	49.12 %
Seq. Revenue Change	-8.43 %	25.9 %	-25.59 %	22.94 %	-2.34 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 70
Healthcare Sector	# 216
Overall Market	# 1901

Receivable Turnover Ratio Statistics
High	Average	Low
35.49	13.93	0.39
(Mar 31 2022)		(Jun 30 2020)

RVNC Company Profile • Back to RVNC Efficiency Comparisons • Compare RVNC Receivables Turnover Ratio to its Competitors

Financial Statements
Revance Therapeutics Inc 's Accounts Receivable	$ 48 Millions	Visit RVNC's Balance sheet
Revance Therapeutics Inc 's Sales TTM	$ 247 Millions	Visit RVNC's Income Statement
Sources of RVNC's Revenues		Visit RVNC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RVNC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RVNC's Growth Rates	RVNC's Roa	RVNC's Inventory Turnover Ratio	RVNC's Dividend Comparisons
RVNC's Profitability Ratios	RVNC's Roi	RVNC's Asset Turnover Ratio	RVNC's Dividend Growth
RVNC's Valuation Ratios	RVNC's Roe	RVNC's Financial Strength Ratios	RVNC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Valion Bio Inc	14.02	$ 0.957 Millions	$ 0.068 Millions
Mannkind Corporation	14.00	$ 267.200 Millions	$ 19.086 Millions
Ispecimen inc	13.70	$ 10.391 Millions	$ 0.758 Millions
Qhslab Inc	13.69	$ 1.821 Millions	$ 0.133 Millions
Lftd Partners Inc	13.08	$ 42.366 Millions	$ 3.239 Millions
Escalon Medical Corp	13.07	$ 11.818 Millions	$ 0.904 Millions
Patterson Companies Inc	13.07	$ 6,555.862 Millions	$ 501.549 Millions
Nrc Health	12.92	$ 144.154 Millions	$ 11.155 Millions
Chemed Corporation	12.84	$ 2,377.206 Millions	$ 185.072 Millions
Vaxart Inc	12.79	$ 16.760 Millions	$ 1.311 Millions
Vsee Health Inc	12.73	$ 8.115 Millions	$ 0.637 Millions
International Stem Cell Corporation	12.65	$ 8.528 Millions	$ 0.674 Millions
Poseida Therapeutics Inc	12.52	$ 150.858 Millions	$ 12.053 Millions
Petvivo Holdings Inc	12.46	$ 0.969 Millions	$ 0.078 Millions
American Oncology Network Inc	12.37	$ 1,592.782 Millions	$ 128.721 Millions
Utah Medical Products Inc	12.05	$ 43.301 Millions	$ 3.593 Millions
Teladoc Health Inc	12.01	$ 2,589.610 Millions	$ 215.544 Millions
Amylyx Pharmaceuticals Inc	11.87	$ 196.485 Millions	$ 16.556 Millions
Rosecliff Acquisition Corp I	11.72	$ 27.264 Millions	$ 2.326 Millions
Lifeloc Technologies Inc	11.71	$ 8.817 Millions	$ 0.753 Millions
Seer Inc	11.63	$ 14.046 Millions	$ 1.208 Millions
Corcept Therapeutics Inc	11.63	$ 628.555 Millions	$ 54.049 Millions
Lipella Pharmaceuticals Inc	11.54	$ 0.484 Millions	$ 0.042 Millions
Siga Technologies Inc	11.52	$ 173.731 Millions	$ 15.075 Millions
Integrated Biopharma Inc	11.52	$ 50.423 Millions	$ 4.376 Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________	11.47	$ 4.037 Millions	$ 0.352 Millions
Exact Sciences Corporation	11.19	$ 2,721.924 Millions	$ 243.223 Millions
Blue Water Vaccines Inc	11.14	$ 1.871 Millions	$ 0.168 Millions
Inogen Inc	11.13	$ 331.520 Millions	$ 29.783 Millions
Jrsis Health Care Corp	10.92	$ 4.726 Millions	$ 0.433 Millions

Date modified: 2026-08-29T17:18:21+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.